38 PHARMACOKINETICS , PHARMACODYNAMICS , AND DRUG DISPOSITION

@inproceedings{Greenblatt200238P,
  title={38 PHARMACOKINETICS , PHARMACODYNAMICS , AND DRUG DISPOSITION},
  author={David J Greenblatt and Lisa L. von Moltke and Jerold S. Harmatz and Richard},
  year={2002}
}
During the last decade, the application of pharmacokinetic and pharmacodynamic modeling techniques has become an increasingly important aspect of contemporary clinical psychopharmacology (1–5). These techniques have been applied during the process of development of new drug entities as well as for the improved understanding of the clinical actions of drugs that are already marketed. Techniques for the study of drug metabolism in vitro have advanced substantially during the last decade, and now… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 16 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 126 REFERENCES

Ketoconazole inhibition of triazolam and alprazolam clearance: differential Neuropsychopharmacology: The Fifth Generation of Progress

  • DJ Greenblatt, CE Wright, LL von Moltke
  • American College of Neuropsychopharmacology
  • 2002

Alprazolamritonavir interaction: implications for product labeling

  • DJ Greenblatt, LL von Moltke, JS Harmatz
  • Clin Pharmacol Ther
  • 2000

Effects of the antifungal agents on oxidative drug metabolism in humans: clinical relevance

  • K Venkatakrishnan, LL von Moltke, DJ. Greenblatt
  • Clin Pharmacokinet
  • 2000
1 Excerpt

Sedative-hypnotic and anxiolytic agents

  • DJ Greenblatt, LL vonMoltke
  • 2000
1 Excerpt

Similar Papers

Loading similar papers…